Partial resistance to citalopram in a Wistar–Kyoto rat model of depression: An evaluation using resting-state functional MRI and graph analysis

• Main Authors: Li, Q. (Author), Liu, S. (Author), Liu, Z. (Author), Pan, W. (Author), Wang, X. (Author), Xu, Y. (Author), Zhao, W. (Author), Zhao, Y. (Author)
• Format: Article
• Language: English
• Published: Elsevier Ltd 2022
• Subjects: Functional connectivity; Graph theory; Resting-state fMRI (rs-fMRI); Selective serotonin reuptake inhibitors (SSRIs); Wistar–Kyoto rats
• Online Access: View Fulltext in Publisher

 Wistar–Kyoto (WKY) rats as an endogenous depression model partially lack a response to classic selective serotonin reuptake inhibitors (SSRIs). Thus, this strain has the potential to be established as a model of treatment-resistant depression (TRD). However, the SSRI resistance in WKY rats is still not fully understood. In this study, WKY and control rats were subjected to a series of tests, namely, a forced swim test (FST), a sucrose preference test (SPT), and an open field test (OFT), and were scanned in a 7.0-T MRI scanner before and after three-week citalopram or saline administration. Behavioral results demonstrated that WKY rats had increased immobility in the FST and decreased sucrose preference in the SPT and central time spent in the OFT. However, citalopram did not improve immobility in the FST. The amplitude of low-frequency fluctuation (ALFF) analysis showed regional changes in the striatum and hippocampus of WKY rats. However, citalopram partially reversed the ALFF value in the dorsal part of the two regions. Functional connectivity (FC) analysis showed that FC strengths were decreased in WKY rats compared with controls. Nevertheless, citalopram partially increased FC strengths in WKY rats. Based on FC, global graph analysis demonstrated decreased network efficiency in WKY + saline group compared with control + saline group, but citalopram showed weak network efficiency improvement. In conclusion, resting-state fMRI results implied widely affected brain function at both regional and global levels in WKY rats. Citalopram had only partial effects on these functional changes, indicating a potential treatment resistance mechanism. © 2022 The Author(s)